Because the patient had a history of multiple tumors, we suggested tumor genetic testing to determine the presence of genetic or chromosomal abnormalities (e.g., tumor suppressor genes, the susceptibility genes BRCA1 and BRCA2) and to determine whether they are associated with the morbidity of these two tumor types, but this recommendation was rejected. Here, BRCA1 is linked to neoplasm.